首页> 外文OA文献 >Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

【2h】

Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

机译：功能性与功能性和解剖标准标准引导的ranibizumab治疗在患有新血管年龄相关的黄斑变性的患者 - 来自随机，IIIB阶段延期研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Giovanni Staurenghi; Justus G. Garweg; Bianca S. Gerendas; Wayne Macfadden; Boris Gekkiev; Philippe Margaron; Cornelia Dunger-Baldauf; Petr Kolar;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study [J] . Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, BMC Ophthalmology . 2020,第1期

机译：功能性与功能性和解剖标准标准引导的ranibizumab治疗在患有新血管年龄相关的黄斑变性的患者 - 来自随机，IIIB阶段延期研究的结果
2. Efficacy and safety of ranibizumab treatment guided by functional and/or anatomical criteria in patients with neovascular age-related macular degeneration: results from the OCTAVE study [J] . Kolar Petr, Staurenghi Giovanni, Dunger-Baldauf Cornelia, Investigative ophthalmology & visual science . 2017,第8期

机译：在新生血管年龄相关黄斑变性患者的功能和/或解剖标准引导的ranibizumab治疗的疗效和安全性：八度研究的结果
3. Efficacy and safety of ranibizumab treatment guided by functional and/or anatomical criteria in patients with neovascular age-related macular degeneration: results from the OCTAVE study [J] . Kolar Petr, Staurenghi Giovanni, Dunger-Baldauf Cornelia, Investigative ophthalmology & visual science . 2017,第8期

机译：在新生血管年龄相关黄斑变性患者的功能和/或解剖标准引导的ranibizumab治疗的疗效和安全性：八度研究的结果
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized phase IIIb OCTAVE study [O] . Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, 2020

机译：新血管性年龄相关性黄斑变性患者的功能功能和解剖学标准指导的兰尼单抗治疗–来自IIIb期OCTAVE随机研究的结果
7. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration [O] . Estefania Cobos, Sergio Recalde, Jaouad Anter, 2017

机译：CFH，CFB，ARMS2，SerpinF1，VEGFR1和VEGF多态性与Ranibizumab治疗在新生血管时代相关性黄斑变性的解剖学和功能反应之间的关系

Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

著录项

引文网络

相似文献

相关主题

期刊订阅